Knowles Earnings Calls
| Release date | Oct 23, 2025 |
| EPS estimate | $0.353 |
| EPS actual | $0.330 |
| EPS Surprise | -6.38% |
| Revenue estimate | 156.225M |
| Revenue actual | 152.9M |
| Revenue Surprise | -2.13% |
| Release date | Jul 24, 2025 |
| EPS estimate | $0.170 |
| EPS actual | $0.0200 |
| EPS Surprise | -88.24% |
| Revenue estimate | 148.55M |
| Revenue actual | 145.9M |
| Revenue Surprise | -1.78% |
| Release date | Apr 24, 2025 |
| EPS estimate | $0.180 |
| EPS actual | $0.180 |
| Revenue estimate | 139.75M |
| Revenue actual | 132.2M |
| Revenue Surprise | -5.40% |
| Release date | Feb 13, 2025 |
| EPS estimate | $0.280 |
| EPS actual | $0.270 |
| EPS Surprise | -3.57% |
| Revenue estimate | 146M |
| Revenue actual | 142.5M |
| Revenue Surprise | -2.40% |
Last 4 Quarters for Knowles
Below you can see how KN performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 13, 2025 |
| Price on release | $18.25 |
| EPS estimate | $0.280 |
| EPS actual | $0.270 |
| EPS surprise | -3.57% |
| Date | Price |
|---|---|
| Feb 07, 2025 | $18.22 |
| Feb 10, 2025 | $18.21 |
| Feb 11, 2025 | $18.31 |
| Feb 12, 2025 | $18.07 |
| Feb 13, 2025 | $18.25 |
| Feb 14, 2025 | $18.29 |
| Feb 18, 2025 | $18.34 |
| Feb 19, 2025 | $18.06 |
| Feb 20, 2025 | $17.84 |
| 4 days before | 0.165% |
| 4 days after | -2.25% |
| On release day | 0.219% |
| Change in period | -2.09% |
| Release date | Apr 24, 2025 |
| Price on release | $15.65 |
| EPS estimate | $0.180 |
| EPS actual | $0.180 |
| Date | Price |
|---|---|
| Apr 17, 2025 | $14.44 |
| Apr 21, 2025 | $14.30 |
| Apr 22, 2025 | $14.40 |
| Apr 23, 2025 | $14.82 |
| Apr 24, 2025 | $15.65 |
| Apr 25, 2025 | $16.09 |
| Apr 28, 2025 | $16.03 |
| Apr 29, 2025 | $15.98 |
| Apr 30, 2025 | $15.74 |
| 4 days before | 8.38% |
| 4 days after | 0.575% |
| On release day | 2.81% |
| Change in period | 9.00% |
| Release date | Jul 24, 2025 |
| Price on release | $18.66 |
| EPS estimate | $0.170 |
| EPS actual | $0.0200 |
| EPS surprise | -88.24% |
| Date | Price |
|---|---|
| Jul 18, 2025 | $17.75 |
| Jul 21, 2025 | $17.96 |
| Jul 22, 2025 | $18.45 |
| Jul 23, 2025 | $19.00 |
| Jul 24, 2025 | $18.66 |
| Jul 25, 2025 | $20.39 |
| Jul 28, 2025 | $20.84 |
| Jul 29, 2025 | $20.84 |
| Jul 30, 2025 | $20.63 |
| 4 days before | 5.13% |
| 4 days after | 10.56% |
| On release day | 9.27% |
| Change in period | 16.23% |
| Release date | Oct 23, 2025 |
| Price on release | $24.01 |
| EPS estimate | $0.353 |
| EPS actual | $0.330 |
| EPS surprise | -6.38% |
| Date | Price |
|---|---|
| Oct 17, 2025 | $23.44 |
| Oct 20, 2025 | $23.80 |
| Oct 21, 2025 | $23.60 |
| Oct 22, 2025 | $23.16 |
| Oct 23, 2025 | $24.01 |
| Oct 24, 2025 | $24.00 |
| Oct 27, 2025 | $23.57 |
| Oct 28, 2025 | $23.49 |
| Oct 29, 2025 | $23.59 |
| 4 days before | 2.43% |
| 4 days after | -1.75% |
| On release day | -0.0416% |
| Change in period | 0.640% |
Knowles Earnings Call Transcript Summary of Q3 2025
Knowles reported a strong Q3 2025 with revenue of $153M (up 7% YoY), non-GAAP EPS of $0.33 (up 22% YoY) and operating cash flow of $29M — all at or above the high end of guidance. By segment: Medtech & Specialty Audio was $65M (up 2% YoY) with gross margins above 50% for the full year expected; Precision Devices was $88M (up 12% YoY) with 41.5% segment gross margin driven by higher utilization in ceramic capacitors and RF microwave products. Management highlighted robust design-win momentum across medtech, defense, industrial and EV/energy markets, with defense demand and bookings particularly strong. The specialty film product line (pulse power / capacitors) is a key growth driver: management expects the energy order plus existing backlog to drive specialty film revenue to roughly $55M–$60M next year, and they are expanding capacity. Q4 guidance: revenue $151M–$161M (midpoint +9% YoY), adjusted EBITDA margin 22%–24%, EPS $0.33–$0.37, operating cash flow $30M–$40M, capex ~$12M for the quarter. Balance sheet/cash actions: $20M of buybacks in Q3, debt reduced, cash $93M, net leverage ~0.6x trailing EBITDA and liquidity >$350M. Company sees tariff exposure as limited (<5% of revenue) and has prebuys to mitigate palladium cost volatility. Management expects sequential gross margin improvement into Q4 and further improvement in 2026 as specialty film ramps, with organic company growth anticipated at the high end (~4%–6%) next year driven by new design-win ramps and specialty film capacity coming online. Management remains open but disciplined on M&A.
Sign In
Buy KN